| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 50.95× | 50.95× | 47.56× | 51.98× | 53.49× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −6.97× | 6.23× | −14.25× | 30.69× | 5.08× | ||
| 0.24× | 0.24× | 0.24× | 0.23× | 0.20× | ||
| 1.59× | 1.59× | 1.56× | 1.85× | 2.21× | ||
| 0.89× | 0.89× | 0.91× | 0.95× | 1.09× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 53.49 | 51.98 | 47.56 | 50.95 | 50.95 | |
| Working Capital Turnover | 5.08 | 30.69 | -14.25 | 6.23 | -6.97 | |
| Asset Turnover | 0.20 | 0.23 | 0.24 | 0.24 | 0.24 | |
| Cash Conversion (CFO/Net Income) | 2.21 | 1.85 | 1.56 | 1.59 | 1.59 | |
| CFO/EBITDA | 1.09 | 0.95 | 0.91 | 0.89 | 0.89 |